Heritage Pharmaceuticals and Apotex Corp. agreed to pay $49.1 million to resolve allegations of price manipulation in the generic drug market, according to a settlement announced Thursday by a coalition of 50 states and territories.
Heritage will pay $10 million in the agreement, while Apotex has provisionally agreed to $39.1 million, pending final approval from participating jurisdictions. Both companies must implement internal reforms to ensure antitrust compliance. All Stat...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In